Comparison of ethanol lock and heparin lock solution as prevention of catheter-related bloodstream infection in hemodialysis patients: systematic review and meta-analysis of randomized controlled trials

Main Article Content

Amy Rosalie
Made Angga Putra
Muhammad Rizki Bachtiar
David Hermawan Christian
Ivan Joalsen

Keywords

Catheter-related bloodstream infection, CRBSI, ethanol lock, hemodialysis, heparin lock

Abstract

Introduction: Catheter-related bloodstream infection (CRBSI) is a common complication of catheter use for vascular access in hemodialysis patients and a major cause of morbidity and mortality. Preventive measures, including antibiotic lock, are inadequate due to the risk of resistance and insufficient effect against bacterial biofilm. Ethanol, an antimicrobial substance, is a potential prophylactic lock-in preventing CRBSI. This study aims to assess ethanol lock's effectiveness in preventing CRBSI in hemodialysis patients with a catheter as vascular access and its impact on catheter dysfunction.


Methods: Researchers systematically searched online databases including Pubmed, Cochrane Library, and Science Direct for relevant randomized controlled trials (RCTs) published within 2011 until 2020. Relevant data were pooled in PICOs (Population, Intervention, Control, Outcomes) format and analyzed with Review Manager (version 5.3.5, Cochrane Collaboration, Denmark).


Results: Seven RCTs involving 453 patients were assessed. The primary outcome indicates that prophylactic ethanol lock significantly reduces the incidence of CRBSI compared to that of heparin lock (RR=0.32, 95% CI 0.12-0.83, p=0.02, heterogeneity I2=68%). The secondary outcome suggests no significant difference in the incidence of catheter dysfunction in ethanol lock and heparin lock (RR=0.75, 95% CI 0.23-2.40, p=0.63, heterogeneity I2=68%).


Conclusion: Ethanol is a potential prophylactic lock agent in preventing CRBSI in hemodialysis patients with catheter access. Further research is needed to synchronize the procedural use of ethanol lock and evaluate its long-term effect.

Abstract 450 | pdf Downloads 284

References

1. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-422D. Available from: http://dx.doi.org/10.2471/blt.17.206441
2. ABDURAHMAN A, Bandiara R, Supriyadi R. MON-055 THE GROWING BURDEN OF END STAGE RENAL DISEASE IN INDONESIA: TEN YEARS OF THE INDONESIAN RENAL REGISTRY REPORTS. Kidney Int Reports. 2019;4(7):S327. Available from: http://dx.doi.org/10.1016/j.ekir.2019.05.843
3. Farida LS, Thaha M, Susanti D. Characteristics of Patients with End-Stage Renal Disease at Dialysis Unit Dr. Soetomo General Hospital Surabaya. Biomol Heal Sci J. 2018;1(2):97. Available from: http://dx.doi.org/10.20473/bhsj.v1i2.9400
4. Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP, et al. Editor’s Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(6):757–818. Available from: http://dx.doi.org/10.1016/j.ejvs.2018.02.001
5. Wish JB, Moe SM. Moving Beyond the Assumed: Improving Fistula Success Rates. J Am Soc Nephrol. 2017;28(10):2827–9. Available from: http://dx.doi.org/10.1681/asn.2017060663
6. Golestaneh L, Mokrzycki MH. Prevention of hemodialysis catheter infections: Ointments, dressings, locks, and catheter hub devices. Hemodial Int. 2018;22(S2):S75–82. Available from: http://dx.doi.org/10.1111/hdi.12703
7. Fisher M, Golestaneh L, Allon M, Abreo K, Mokrzycki MH. Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 2019;15(1):132–51. Available from: http://dx.doi.org/10.2215/cjn.06820619
8. Kubiak DW, et al. Adjunctive management of central line-associated bloodstream infections with 70 % ethanol-lock therapy. J Antimicrob Chemother. 2014;69:1665–8.
9. Landry DL, Jaber RA, Hanumanthappa N, Lipkowitz GS, O’Shea MH, Bermudez H, et al. Effects of Prolonged Ethanol Lock Exposure to Carbothane- and Silicone-based Hemodialysis Catheters: A 26-week Study. J Vasc Access. 2015;16(5):367–71. Available from: http://dx.doi.org/10.5301/jva.5000397
10. Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587–98. Available from: http://dx.doi.org/10.1038/ki.2010.471
11. Alonso B, Pérez-Granda MJ, Latorre MC, Rodríguez C, Sánchez-Carrillo C, Muñoz P, et al. Correction: Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model? PLoS One. 2019;14(8):e0221702. Available from: http://dx.doi.org/10.1371/journal.pone.0221702
12. Landry D, Braden G. Reducing Catheter-Related Infections in Hemodialysis Patients. Clin J Am Soc Nephrol. 2014;9(7):1156–9. Available from: http://dx.doi.org/10.2215/cjn.04700514
13. Zhao T, Liu H, Han J. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(9):1643–52. Available from: http://dx.doi.org/10.1007/s11255-018-1855-4
14. Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients – the HEALTHY-CATH trial. BMC Nephrol. 2012;13(1). Available from: http://dx.doi.org/10.1186/1471-2369-13-146
15. Sishir G, Bhupeshkumar K, Umapati H, Kalpesh G, Mohan R. To study the efficacy of intraluminal 70% ethanol vs heparin lock prior to hemodialysis in prevention of infections in non-tunneled hemodialysis catheters: a randomised study. Nephrology. 2014;19:181–2.
16. Sun X. Ethanol versus Heparin Catheter Locks for Cuffed Central Venous Catheters in Hemodialysis Patients: A Single-center Randomized Controlled Trial. [Internet]. Southeast University; 2014. Available from: http://www.wanfangdata.com.cn/details/detail.do?_type=degree&id=Y2706576
17. Shrestha SKD, Raut KB. Role of Ethanol Lock Therapy Vs Heparin Lock In Preventing Infections in Non-Tunneled Hemodialysis Catheters. J Univers Coll Med Sci. 2015;3(4):30–6. Available from: http://dx.doi.org/10.3126/jucms.v3i4.24266
18. Vercaigne LM, Allan DR, Armstrong SW, Zacharias JM, Miller LM. An Ethanol/Sodium Citrate Locking Solution Compared to Heparin to Prevent Hemodialysis Catheter-Related Infections: a Randomized Pilot Study. J Vasc Access. 2015;17(1):55–62. Available from: http://dx.doi.org/10.5301/jva.5000486
19. Sofroniadou S, Revela I, Kouloubinis A, Makriniotou I, Zerbala S, Smirloglou D, et al. Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: A prospective randomized study. Hemodial Int. 2017;21(4):498–506. Available from: http://dx.doi.org/10.1111/hdi.12524
20. Yang J., Liu H, Gao M, She L., Zhang L., Wang Y. Application of ethanol locks in maintenance hemodialysis patients with long-term catheter indwelling. Chin J Nosocomiol. 2013;23:318–9.
21. Zhang P, Su X-J, Wang X-H. Comment on the original article entitled “Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis.” Int Urol Nephrol. 2018;50(9):1743. Available from: http://dx.doi.org/10.1007/s11255-018-1894-x
22. Zhang J, Wang B, Wang J, Yang Q. Ethanol locks for the prevention of catheter-related infection in patients with central venous catheter: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2019;14(9):e0222408. Available from: http://dx.doi.org/10.1371/journal.pone.0222408
23. Daoud DC, Wanten G, Joly F. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition. Nutrients. 2020;12(2):439. Available from: http://dx.doi.org/10.3390/nu12020439
24. Merikhi A, et al. Comparison of the effect of antibiotic-lock and ethanol-lock methods on infection rate in children with hemodialysis catheter. Am J Clin Exp Urol. 2019;7(6):384–90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971476/pdf/ajceu0007-0384.pdf.
25. Schilcher G, Schlagenhauf A, Schneditz D, Scharnagl H, Ribitsch W, Krause R, et al. Ethanol Causes Protein Precipitation—New Safety Issues for Catheter Locking Techniques. PLoS One. 2013;8(12):e84869. Available from: http://dx.doi.org/10.1371/journal.pone.0084869
26. Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother. 2014;69(10):2611–9. Available from: http://dx.doi.org/10.1093/jac/dku182